Christopher Robert BEBBINGTON,Bradford Andrew YOUNGBLOOD,Nenad TOMASEVIC,Emily C. BROCK
申请号：
US16610429
公开号：
US20200270344A1
申请日:
2018.05.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods for the treatment of inflammatory bowel disease (IBD) or an eosinophilic gastrointestinal disorder (EGID), such as eosinophilic esophagitis (EOE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE), and eosinophilic colitis (EC). In particular, the present disclosure provides methods for the treatment of IBD or an EGID through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of IBD or an EGID.
